QR Kodea

Respiratory Syncytial Virus Prevention through Monoclonal Antibodies: A Cross-Sectional Study on Knowledge, Attitudes, and Practices of Italian Pediatricians

Respiratory Syncytial Virus (RSV) is a leading cause of morbidity and hospitalization in all infants. Many RSV vaccines and monoclonal antibodies (mAb) are currently under development to protect all infants, but to date preventive options are available only for preterms. In this study, we assessed t...

Deskribapen osoa

Gorde:
Egile Nagusiak: Matteo Riccò, Silvia Corrado, Milena Pia Cerviere, Silvia Ranzieri, Federico Marchesi
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: MDPI AG 2023-02-01
Saila:Pediatric Reports
Gaiak:
RSV
RSV all infants
RSV epidemiology
RSV pediatric burden
RSV prevention
RSV vaccines
Sarrera elektronikoa:https://www.mdpi.com/2036-7503/15/1/13
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Antzeko izenburuak